Gyre Therapeutics (L9S.F) Q2 2024 Earnings

9MayConfirmed
Q2 2024
0.03
0.36
0.69
1.03

Details

Expected EPS
N/A
Actual EPS
0.027816
Surprise EPS
0.03
Surprise Percent
+∞%

Description

Gyre Therapeutics (L9S.F) has reported earnings of 0.027816 per share for Q2 2024.

0 Comments

Share your thoughts